HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anti-inflammatory, antioxidant and anti-acetylcholinesterase activities of Bouvardia ternifolia: potential implications in Alzheimer's disease.

Abstract
Bouvardia ternifolia has been used medicinally to treat inflammation. In the present study, we investigate the anti-Alzheimer's potential effect of the hydroalcoholic extract of B. ternifolia through evaluation of anti-inflammatory and antioxidant activities, quantification of the percentage inhibition of acetylcholinesterase activity, protection effect against β-amyloid fibrillar-induce neurotoxicity, and the identification of the main constituents. Our results show that B. ternifolia extract and ethyl acetate fraction induced anti-inflammatory effects by reducing inflammation by >70 %, while antioxidant test revealed significant IC50 values for flavonoid content fraction (30.67 ± 2.09 μg/ml) and ethyl acetate fraction (42.66 ± 0.93 μg/ml). The maximum inhibition of acetylcholinesterase was exhibited by scopoletin content fraction (38.43 ± 3.94 %), while ethyl acetate fraction exerted neuroprotective effect against β-amyloid peptide (83.97 ± 5.03 %). Phytochemical analysis, showed the presence of 3-O-quercetin glucopyranoside (415 mg/g), rutin (229.9 mg/g), ursolic and oleanolic acid (54 and 20.8 mg/g respectively), 3-O-quercetin rhamnopyranoside (12.8 mg/g), chlorogenic acid (9.5 mg/g), and scopoletin (1.38 mg/g). Our findings support the use of B. ternifolia since the extract induced significant neuroprotection against β-amyloid peptide, anti-inflammatory, antioxidant and anti-acetylcholinesterase effects that could be attributed to its contents of polyphenols, coumarins, and triterpenes, and encourage further studies for development of this extract as therapeutic agent in treatment of Alzheimer's disease.
AuthorsGiovanni García-Morales, Maira Huerta-Reyes, Manasés González-Cortazar, Alejandro Zamilpa, Enrique Jiménez-Ferrer, Raúl Silva-García, Rubén Román-Ramos, Arturo Aguilar-Rojas
JournalArchives of pharmacal research (Arch Pharm Res) Vol. 38 Issue 7 Pg. 1369-79 (Jul 2015) ISSN: 1976-3786 [Electronic] Korea (South)
PMID25740217 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Amyloid beta-Peptides
  • Anti-Inflammatory Agents
  • Antioxidants
  • Cholinesterase Inhibitors
  • Coumarins
  • Flavonoids
  • Neuroprotective Agents
  • Peptide Fragments
  • Phenols
  • Plant Extracts
  • Triterpenes
  • amyloid beta-protein (1-42)
Topics
  • Alzheimer Disease (drug therapy, metabolism)
  • Amyloid beta-Peptides (antagonists & inhibitors)
  • Anti-Inflammatory Agents (isolation & purification, pharmacology)
  • Antioxidants (isolation & purification, pharmacology)
  • Cell Survival (drug effects)
  • Cholinesterase Inhibitors (isolation & purification, pharmacology)
  • Coumarins (isolation & purification, pharmacology)
  • Flavonoids (pharmacology)
  • Humans
  • Neuroprotective Agents (isolation & purification, pharmacology)
  • Peptide Fragments (antagonists & inhibitors)
  • Phenols (isolation & purification, pharmacology)
  • Plant Components, Aerial (chemistry)
  • Plant Extracts (chemistry, pharmacology)
  • Rubiaceae (chemistry)
  • Triterpenes (isolation & purification, pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: